---
title: "\"Performance\" GLOBAL BIO-CHEM's mid-term loss narrowed to 155 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255331778.md"
description: "GLOBAL BIO-CHEM announced its interim results for the six months ended June, with revenue recorded at 1.186 billion yuan, an increase of 32% year-on-year. The loss narrowed from 158 million yuan in the same period last year to 155 million yuan, with a loss per share of 1.7 cents. No dividend was declared"
datetime: "2025-08-31T07:53:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255331778.md)
  - [en](https://longbridge.com/en/news/255331778.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255331778.md)
---

# "Performance" GLOBAL BIO-CHEM's mid-term loss narrowed to 155 million yuan

GLOBAL BIO-CHEM (00809.HK) announced its interim results for the six months ended June, with revenue recorded at HKD 1.186 billion, an increase of 32% year-on-year. The loss narrowed from HKD 158 million in the same period last year to HKD 155 million, with a loss per share of 1.7 cents. No dividend was declared

### Related Stocks

- [00809.HK](https://longbridge.com/en/quote/00809.HK.md)

## Related News & Research

- [Krugman on Hassett economic growth projections: ‘We haven’t had that in generations’](https://longbridge.com/en/news/282391603.md)
- [PegBio Wins China Nod for Hong Kong Share Full Circulation](https://longbridge.com/en/news/282277506.md)
- [China's March soybean imports rise 14.9% from a year ago](https://longbridge.com/en/news/282622541.md)
- [Alstom ADR (OTCMKTS:ALSMY) Short Interest Update](https://longbridge.com/en/news/282438036.md)
- [Genscript Biotech Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority](https://longbridge.com/en/news/282529201.md)